Jiangsu Hengrui Medicine
600276.SS
#479
Rank
โ‚น3.611 T
Marketcap
โ‚น566.08
Share price
-1.82%
Change (1 day)
3.25%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Market capitalization of Jiangsu Hengrui Medicine (600276.SS)

Market cap: โ‚น3.611 Trillion

As of November 2024 Jiangsu Hengrui Medicine has a market cap of โ‚น3.611 Trillion. This makes Jiangsu Hengrui Medicine the world's 479th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jiangsu Hengrui Medicine from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น3.611 T6.7%
2023โ‚น3.384 T16.05%
2022โ‚น2.916 T-23.03%
2021โ‚น3.788 T-43.15%
2020โ‚น6.663 T68.64%
2019โ‚น3.951 T100.09%
2018โ‚น1.974 T3.96%
2017โ‚น1.899 T81.76%
2016โ‚น1.045 T6.05%
2015โ‚น985.39 B70.79%
2014โ‚น576.96 B9.4%
2013โ‚น527.38 B61.35%
2012โ‚น326.86 B17.79%
2011โ‚น277.49 B-8.26%
2010โ‚น302.48 B36.64%
2009โ‚น221.37 B57.53%
2008โ‚น140.53 B6.92%
2007โ‚น131.43 B116.32%
2006โ‚น60.76 B189.55%
2005โ‚น20.98 B25.93%
2004โ‚น16.66 B41.38%
2003โ‚น11.78 B-20.56%
2002โ‚น14.83 B-29.36%
2001โ‚น21.00 B-7%
2000โ‚น22.58 B